Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Crown fruit leafy shoots refer to the young leaves and branches of *Xanthoceras sorbifolium* Bunge, also known as yellowhorn. This plant is native to northern China and has a long history of use in traditional Chinese and Mongolian medicine. It is being investigated for its potential in treating metabolic syndrome. Pharmacological studies on *Xanthoceras sorbifolium* have demonstrated various activities, including anti-inflammatory, anti-oxidative, anti-tumor, neuroprotective, hypoglycemic, and lipid-lowering effects. The leaves specifically contain bioactive compounds such as flavonoids, polyphenols, alkaloids, and saponins, and have shown to ameliorate type 2 diabetes mellitus by modulating glucolipid metabolism through the gut microbiota-metabolite axis. It is traditionally consumed as an herbal tea and has been approved as a new food ingredient in China.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on crown fruit leafy shoots.